Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities
Case Presentations/Panel Discussion: 80 y/o M With Melanoma, 67 y/o M With Stage 3A NSCLC, 55 y/o F With Metastatic Melanoma
Login to view comments.
Click here to Login
Videos